GB2454923B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB2454923B
GB2454923B GB0723018A GB0723018A GB2454923B GB 2454923 B GB2454923 B GB 2454923B GB 0723018 A GB0723018 A GB 0723018A GB 0723018 A GB0723018 A GB 0723018A GB 2454923 B GB2454923 B GB 2454923B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB0723018A
Other versions
GB0723018D0 (en
GB2454923A (en
Inventor
Andrew John Duffield
Roger Anthony Oakes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IVY MEDICAL CHEMICALS PLC
Original Assignee
IVY MEDICAL CHEMICALS PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IVY MEDICAL CHEMICALS PLC filed Critical IVY MEDICAL CHEMICALS PLC
Priority to GB0723018A priority Critical patent/GB2454923B/en
Publication of GB0723018D0 publication Critical patent/GB0723018D0/en
Publication of GB2454923A publication Critical patent/GB2454923A/en
Application granted granted Critical
Publication of GB2454923B publication Critical patent/GB2454923B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0723018A 2007-11-23 2007-11-23 Pharmaceutical compositions Active GB2454923B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0723018A GB2454923B (en) 2007-11-23 2007-11-23 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0723018A GB2454923B (en) 2007-11-23 2007-11-23 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
GB0723018D0 GB0723018D0 (en) 2008-01-02
GB2454923A GB2454923A (en) 2009-05-27
GB2454923B true GB2454923B (en) 2011-04-20

Family

ID=38925966

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0723018A Active GB2454923B (en) 2007-11-23 2007-11-23 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB2454923B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3494980A1 (en) * 2017-12-08 2019-06-12 Oguzhan Doganlar Spider web extract, method of preparation, and use for treating prostate cancer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030324A2 (en) * 1999-10-27 2001-05-03 Aufsess Joachim G Use of acetylsalicylic acid and a preparation for treatment of prostatic hyperplasia
US20040248858A1 (en) * 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
WO2006136008A1 (en) * 2005-05-24 2006-12-28 University Health Network Salicylic acid hydrazones as inhibitors of the erk mapkinase pathway and for the treatment of cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030324A2 (en) * 1999-10-27 2001-05-03 Aufsess Joachim G Use of acetylsalicylic acid and a preparation for treatment of prostatic hyperplasia
US20040248858A1 (en) * 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
WO2006136008A1 (en) * 2005-05-24 2006-12-28 University Health Network Salicylic acid hydrazones as inhibitors of the erk mapkinase pathway and for the treatment of cancer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"CV247" [Online], published/last modified Oct 2006. Available from: http://www.cancernet.co.uk/cv247.htm [Accessed 18 March 2008]. *
Hematology-Oncology Clinics of North America, Vol. 20, No. 4, Aug 2006, J M Chan, et al., "The epidemiology of prostate cancer - with a focus on nonsteroidal anti-inflammatory drugs", pages 797-809. *
International Journal of Oncology, Vol. 23, No. 5, Nov 2003, F P Lloyd, et al, "Aspirin inhibits highly invasive prostate cancer cells.", pages 1277-1283. *
Nutrition & Food Science, Vol. 35, No. 6, 2005, R Thomas, et al. "Dietary advice combined with a salicylate, mineral and vitamin supplement (CV247) has some tumour static properties: a phase II study" pages 436-451. *
QJ Med, Vol. 94, No. 8, JR Paterson et al., "Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer", pages 445-8. *

Also Published As

Publication number Publication date
GB0723018D0 (en) 2008-01-02
GB2454923A (en) 2009-05-27

Similar Documents

Publication Publication Date Title
HUS1800007I1 (en) Pharmaceutical composition
IL247741A0 (en) Pharmaceutical compositions
EP2133095A4 (en) Pharmaceutical composition
EP2133094A4 (en) Pharmaceutical composition
EP2191826A4 (en) Pharmaceutical composition
EP2222313A4 (en) Pharmaceutical compositions
IL200125A0 (en) Pharmaceutical composition
EP2224805A4 (en) Pharmaceutical composition
EP2224915A4 (en) Pharmaceutical composition
EP2146695A4 (en) Pharmaceutical compositions
HK1138774A1 (en) Pharmaceutical composition
EP2224808A4 (en) Pharmaceutical composition
GB0709811D0 (en) Pharmaceutical compositions
EP2156832A4 (en) Pharmaceutical composition
GB0707127D0 (en) Pharmaceutical compositions
EP2224806A4 (en) Pharmaceutical composition
IL205975A0 (en) Pharmaceutical composition
GB0712454D0 (en) Pharmaceutical compositions
GB2454923B (en) Pharmaceutical compositions
IL201394A0 (en) Niacin - based pharmaceutical compositions
IL205931A0 (en) Pharmaceutical composition
GB0709603D0 (en) Pharmaceutical compositions
GB0706657D0 (en) Pharmaceutical compositions
GB0701367D0 (en) Novel pharmaceutical compositions
GB0701368D0 (en) Novel pharmaceutical compositions

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20130516 AND 20130522